Razis Evangelia

Razis Evangelia Internist Oncologist

Director 3rd Oncology Department, Director Contemporary Oncology Team

Education & Academic Qualifications

  • Northwestern University, Chicago, IL – 6 year Honors Program in Medical Education – BS in Medical Science – June 1985, M.D. – June 1987.
  • Beth Israel Medical Center, New York, NY – 3 year Internal Medicine Residency, July 1, 1987 – June 30, 1990.
  • New York Medical College/Westchester County Medical Center – 2 year Oncology Fellowship – July 1, 1990 – June 30, 1992.
  • New York Medical College/Westchester County Medical Center – 1 year Bone Marrow Transplantation Fellowship, July 1992 – June 1993.
  • Instructor of Medicine, New York Medical College – July 1993 – Dec. 1993.
  • Ph.D. in Medicine, July 1998: “Phase II, High Dose Chemotherapy with peripheral stem cell support in early high risk breast cancer”, University of Crete, Department of Medicine.

­Certifiaction / Licensure

  • National Board of Medical Examiners – 06/1985 – 04/1987 – 03/1988 – 01/1988.
  • American Board of Internal Medicine – September 12, 1990.
  • American Board of Medical Oncology, U.S.A. – November 1995, 2005, 2015.
  • Greek Specialty Board of Internal Medicine. March 1994
  • Full medical license in Greece – License number: 7383/29/03/93.
  • New York medical license number: 197952. (Inactive).
  • Pennsylvania – License number: 046278L. (Inactive).
  • Greek Specialty Board of Medical Oncology. April 2000.
  • European Society for Medical Oncology (ESMO) Certification (2003). Recertification 2008, 2013. (Validity of Certificate until 2018).


Fellowship in Societies, Membership in Journal Editorial Committees

  • American Society of Clinical Oncology (ASCO).

  • American Association for Cancer Research (AACR).

  • Society for Neuro-Oncology (SNO).

  • National Cancer Institute (NCI) Investigator.

  • European Society of Medical Oncology (ESMO).

  • European Association of Neuro-Oncology (EANO).

  • European Society of Mastology (EUSOMA).

  • European Organization for Research and Treatment of Cancer (EORTC) Brain Tumor Group.

  • European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group.

  • European Organization for Research and Treatment of Cancer (EORTC) Brain Tumor Group Quality Assurance Committee.

  • Mediterranean Multidisciplinary Oncology Forum (MMOF).

  • Hellenic Society of Medical Oncology (HeSMO).

  • Hellenic Cooperative Oncology Group (HeCOG).

  • Medical Union of Hygeia Hospital.

  • Greek Medical Association.

  • Athens Medical Association (Member number: 037015).

  • Greek Society of Senology.

  • Greek American Medical Association.

  • Hellenic NeuroOncology Group Group (HeNOG).

  • Hellenic Society of Head and Neck Oncology (HeSHNO).

Journal Editing

  • Forum of Clinical Oncology (FCO).

  • World Journal of Clinical Oncology (WJCO).

  • Cancer Treatment Reviews (CTR, Occ Reviewer of papers).

  • Mediterranean Oncology Journal (MOJ) – Central Nervous System Team.

Other Boards

  • Member of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), as a representative of Greece in the “ATLAS” (Adjuvant Tamoxifen Longer Against Starter) study, with an active presence in the meetings of 09/2005, 09/2010 and 09/2012.

  • HeCOG representative in the Breast International Group (BIG).

  • Reviewer of the National Cancer Control Plans (NCCP) of the Union for International Cancer Control (UICC) and the World Health Organization (WHO).

  • Chairperson for HeCOG working party on CNS tumors.

  • Has served as Director and Assistant Director of Hygeia Hospital Pharmacy Committee.


Work Experience

  • Mental Health Worker – Adolescent Psychiatric Unit, Northwestern Memorial Hospital, 1984 – 1986.

  • Internal Medicine Intern and Resident – Beth Israel Medical Center July 1987- June 1990.

  • Oncology Fellow – Westchester County Medical Center/New York Medical College July 1990 – July 1993.

  • Instructor New York Medical College, July 1993 – December 1993.

  • Oncology Attending – Hygeia Hospital, January 1994 – December 1997.

  • Associate Director – 1st Department of Medical Oncology, Hygeia Hospital, January 1998 – August 2011.

  • Director, 3rd Department of Medical Oncology, Hygeia Hospital, September 2011 – to date.

  • Founding member of the Contemporary Oncology Team (COT).

Teaching Experience

  • Taught in many teaching seminars for oncology students and oncologists.

  • Supervised the Masters Theses of two medical students.

  • Regularly teaches:

    • Graduate students who attend the HYGEIA Hospital quarterly postgraduate course.

    • Dentist graduate and undergraduate students at the University of Athens School of Dentistry.

    • Nursing Seminars at HYGEIA Hospital.

    • Oncology trainees in courses organized by the Greek Academy of Oncology and the European School of Oncology.

Charity Work

Evangelia Razis has travelled extensively in many countries of Africa, Asia and South/Central America. She has worked voluntarily in the Sudan, giving lectures to women on breast and cervical cancer awareness and prevention and to the staff of the Radiotherapy Institute of Khartum (RIK), in Sri Lanka, in the Honduras, in Zimbabwe, in Rwanda and in Kefalonia, Greece.

Quality Assurance

Dr Razis led the Contemporary Oncology Team (COT) through the process of ASCO’s Quality in Oncology Practice Initiative (QOPI) participation and certification (QCP), and COT was the first practice outside the USA to achieve this certification. Additionally, she is president of the Quality Assurance Committee of the European Organization for Research and Treatment of Cancer (EORTC) Brain Tumor Group, and a member of the ASCO QOPI Steering Group.



  • E.Razis. Chemotherapy for malignant gliomas in adults: ”Recent Advances in Treatment of Cerebral Gliomas”,2002. Ed, M.Torrens, E.Razis, H.Strongylos pp 107- 136. 

  • E.Razis, Monoclonal Antibodies and other biological agents for Breast Cancer “Modern Mastology” 2007. Ed L. Mouzaka, A. Mandrekas, V. Barbounis. Pp953-960.

  • E.Razis and G. Fountzilas. Trastuzumab Resistance. 2010, In: Aggressive Breast Cancer, Ed: Regina H. DeFrina. pp. 187-197, Nova Science Publishers, Inc.


Recent Publications